Research Articles
LKEKK: The Tiny Peptide That Could Revolutionize Tuberculosis Treatment
Discover how the synthetic peptide LKEKK shows promising antituberculosis action by enhancing immune functions and fighting drug-resistant TB strains.
The Hidden Enemy: Hunting for New Weapons Against Dormant Tuberculosis
Exploring scientific breakthroughs in targeting dormant tuberculosis infections through novel drugs, diagnostics and host-directed therapies
The Hidden Battle: How Doctors Stop TB in Patients on Life-Changing Treatments
Exploring how TNF-alpha blockers increase TB risk and the successful prevention strategies developed through medical research.
The Invisible Danger: When a Routine Procedure Turns Deadly
Exploring multidrug-resistant tuberculosis transmission through needlestick injuries in healthcare workers - a comprehensive analysis of risks, cases, and prevention strategies.
Unseen Battle: How Your Innate Immune System Fights Tuberculosis
Discover how your body's innate immune system detects and fights Mycobacterium tuberculosis, the bacterium causing tuberculosis.
Unlocking Macrophage Secrets: How a "Wrong Turn" in Immune Defense Makes TB So Deadly
Discover how Mycobacterium tuberculosis hijacks the immune system by manipulating macrophage signaling pathways through RIG-I activation.
Cracking the Fortress: How TB Drugs Penetrate the Lungs' Battlefield
Discover how pharmacokinetic research reveals how tuberculosis drugs penetrate lung lesions in rabbit models, shaping future TB treatments.
The Hidden Connection: How Tuberculosis Can Trick Your Immune System
Discover how tuberculosis can trigger autoimmune markers and the groundbreaking research revealing this reversible phenomenon.
The Hidden Enemy: When TB Tests Fail During Biologic Therapy
Exploring the paradoxical reality of TB reactivation during biologic therapy and the diagnostic challenges of false-negative test results.
Breathing New Life into TB Treatment: The Calcitriol Dry Powder Breakthrough
Exploring the innovative use of calcitriol dry powder inhalation as a host-directed adjunct therapy for tuberculosis treatment.